Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
An Overview of Genital Stromal
Tumors
By Konstantinos Linos MD, FCAP, FASDP
Bone, Soft Tissue and Dermatopathology
Assistant Professor of Pathology
Dartmouth-Hitchcock Medical Center
Geisel School of Medicine at Dartmouth
Hanover, NH, USA
• Book Royalties
Financial disclosures
• Broad variety of soft tissue tumors exclusively
in vulvovaginal and inguinoscrotal sites
• Probably originate from a distinct zone of
subepithelial stromal cells or subepithelial
mesenchyme extending from the
endocervix
• Striking morphologic, immunophenotypic and
genetic overlap
General
• Fibroepithelial Polyp
• Superficial Myofibroblastoma
• Cellular angiofibroma
• Mammary-type myofibroblastoma
• Angiomyofibroblastoma
• Deep/”Aggressive” angiomyxoma
• Superficial Angiomyxoma
• Prepubertal Vulvar Fibroma
• Lipoblastoma-Like tumor of the vulva
• Smooth Muscle Tumors of the external
genitalia
• Synonyms
• Mesodermal stromal polyp
• Cellular Pseudosarcomatous fibroepithelial
stromal polyp
• Pseudosarcoma botryoides
• Benign polypoid growth of the vagina, vulva or
cervix
• Strongly tied to hormonal stimulation
Fibroepithelial Stromal Polyp
• Most often during pregnancy
• also in reproductive age women
• Postmenopausal women undergoing hormonal
replacement
• Regression in the postpartum period is typical
• Typical clinical presentation is one or more
polyps that may be symptomatic
• Usually 1-5cm
Immunohistochemistry
• Consistently reactive for
• Desmin
• Estrogen Receptor (ER)
• Progesetrone Receptor (PR)
• Sometimes Smooth Muscle Actin
Enbryonal
Rhabdo-
myosarcoma
Rhabdomyoma
Superficial (cervicovaginal)
myofibroblastoma• Benign tumor that may arise in the vulva,
vagina or cervix
• Nodular or polypoid painless mass in adults
most commonly in their 50s
• Grossly well-circumscribed, firm and dense
mass from 1 to 6.5cm
Immunohistochemistry
• Desmin in 75-100% of cases
• ER/PR in 80-100%
• CD34 in 50-85%
• SMA in 0-45%
Cellular Angiofibroma• Synonym
• Angiomyofibroblastoma-like tumor of the
male genital tract
• Benign neoplasm in vulvovaginal and
inguinoscrotal areas
• Middle-aged patients with a female
predominance
• Classically subcutaneous painless nodule
usually not exceeding 7cm
Immunohistochemistry
• Inconsistent expression
• Variable expression of
CD34, desmin, SMA
• P16 positivity in
sarcomatous areas
p16
Mammary-type
Myofibroblastoma• Initially described in breast
• Can arise anywhere in soft tissue
• Predilection for inguinal and pelvic region
• Most cases occur in men
• Median age 53
• Range 1-22cm (median size of 6cm)
Immunohistochemistry
• Frequently
positive for
CD34 and
Desmin
(~90%)
• Rare cases
negative for
both (~3%)
CD34 Desmin
• Benign tumor
• Local excision curative
• No evidence of significant recurrence risk even
in the presence of positive resection margins
Prognosis
RB1 and Genital Stromal Tumors
Mammary-type
myofibroblastoma
Cellular
Angiofibroma
RB1
RB1
• Benign mesenchymal neoplasm of the vulva
and vagina
• Uncommonly may present as a penduculated
lesion
• Most grossly well-circumscribed and smaller
than 5cm
Angiomyofibroblastoma
Immunohistochemistry
• Positive for
Desmin, ER &PR
• Less commonly
CD34 and SMA
positivity
Desmin
• Synonym: “Aggressive” angiomyxoma
• Low Grade, locally infiltrative myxomatous
neoplasm specific to the deep vulvovaginal,
perineal and pelvic tissues
• Strong female predisposition
• In men in the analogous inguinoscrotal and
perineal regions
• Usually 4th decade of life with painless cystic
mass often exceeding 10cm
Deep Angiomyxoma
• Less aggressive course than initially described
if completely excised with negative margins
• Potential for local destructive recurrence some
times years (often decades) after initial
excision
• Even tumors as small as 3cm have recurred
multiple times
• Grossly soft gelatinous tumor with ill-defined
margins
• In recurrent cases may have more fibrous
appearance
Immunohistochemistry• Typically positive for:
• Desmin
• SMA
• ER/PR
• Variable CD34 positivity
• Structural rearrangements of the region 12q15
• ~30% of tumors, intragenic/extragenic
• HMGA2 and CDK4 IHCs positive
• When positive, useful in confirming the diagnosis
and assessing margins status in a subset of cases
Reactive changes Smooth Muscle Tumor
WDL Superficial Angiomyxoma
Superficial Angiomyxoma• Can also occur in the genital region of women
• Include this entity in the differential of
myxoid lesions of the distal female genital
tract
• Association with Carney complex less clear
with lesions in the genital area
• Typically polypoid and usually less than 5cm
• Potential for local nondestructive recurrence in
~30-40% of cases
Prepubertal Vulval Fibroma
Myxoid Collagenous
Loss of RB1 by IHC
• Lack of PLAG1 and HMGA2
expression suggests it is
distinct from “true”
lipoblastomas
• Loss of Rb1 suggests
possible role of 13q
chromosomal alterations
• Possible relationship with the
Spindle cell lipoma family
Practical approach
• Correct Identification of Aggressive
Angiomyxoma is critical
• If above has been excluded and definitive
classification is not possible you can use label
• “Benign Genital Stromal Tumor”
Smooth Muscle Tumors of the
External Genitalia• Smooth muscle tumors of vulva, vagina, and
scrotum have similar gross and pathologic
features to soft tissue and uterine counterparts
• Criteria for malignancy depend on the specific
site
• Soft tissue
• Superficial (including nipple)
• Genital
• Deep seated
Epithelioid morphology
Myxoid changes
LEIOMYOMA
LEIOMYOSARCOMA
Some combination of
• cytologic atypia,
• increased mitotic
activity
• Increased size
• infiltrative growth
Smooth Muscle Tumors of the
Vulva• Leiomyomas of the vulva is one of the more
common vulvar mesenchymal neoplasms
• Present in 4th to 5th decade as a small (<3cm)
mass
• Mutliple leiomyomas may be manifestation of
Alport Syndrome
• Hereditary disorder
• Glomerulonephritis, ocular abnormalities & hearing
loss
• Mutation in COL4A3, COL4A4, COL4A5
Smooth Muscle Tumors of the
Scrotum • Uncommon and most are leiomyosarcomas
• Cytologic atypia, mitotic activity and necrosis
• Rare in this location tumors with absence of
atypia or mitotic activity
• Extensive sample is necessary before apply the
diagnosis of leiomyoma
• Note long-term clinical follow-up
• Any mitotic activity warrants classification
as malignant
• Neurofibroma
• S100-protein/SOX 10 +
• Solitary Fibrous Tumor
• STAT6 positive
• Inflammatory Myofibroblastic Tumor
• ALK + in 50-60% of cases
• Sarcomatoid Carcinoma
• Diffuse cytokeratin expression
• Examine for High Grade Squamous Intraepithelial
lesion or dVIN
Differential Diagnosis